2026 NPPES data Internal Medicine Physician NPI 1578003430 MD
Verify on CMS →

SHILPA AKULA, MD

Internal Medicine Physician in ELMIRA, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 194 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.3099/100
▼ 2 pts below national avg 83.1 · [object Object]
Industry payments
$213.65
10 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SHILPA AKULA, MD reported a CMS MIPS final score of 81.3099/100 — below the 83.1 national average — and filed 2,337 Medicare Part D claims in 2023.

81.3099/100
MIPS score · -2 vs avg
2K
Part D claims, 2023
89%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SHILPA AKULA, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

81 36th percentile higher than 36% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

SHILPA AKULA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SHILPA AKULA, MD?

Near national average

NPI registry status

Active

Issued 02/26/2017

NPI 1578003430

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

2,337 14% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

MIPS final score

81.3099/100 1.7900999999999954% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Internal Medicine Physician compares to other specialties among New York providers

New York providers

Internal Medicine Physician share within New York

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within New York

Medicare quality performance — MIPS

SHILPA AKULA, MD's 2023 MIPS final score plotted against the Internal Medicine Physician national average

Near national average
MIPS Final Score
81.3099/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Internal Medicine Physician) — 81.3099/100 vs national avg 83.1

0%100%National avg83%81.3%
MIPS final score (Internal Medicine Physician) — 81.3099/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SHILPA AKULA, MD appears in the CMS NPPES registry as a Internal Medicine Physician provider holding MD credentials at 200 MADISON AVE FL 3, ELMIRA, NY, 14901, with a listed phone of (607) 734-1581. NPI 1578003430 was issued on 02/26/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AKULA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,337 prescription claims written by this provider, covering 194 Medicare beneficiaries and totaling roughly $171K in drug spend, split 11% brand-name and 89% generic by claim count, with an opioid prescribing rate of 3.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.3099/100 for the 2023 performance year (Quality 61.8029, Cost 65.2131), compared with the national average of 83.1.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

200 MADISON AVE FL 3
ELMIRA, NY 14901

Provider Details

NPI 1578003430
Specialty Internal Medicine Physician
Credentials MD
Gender Female
NPI Issued 02/26/2017

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

81.3099
Final Score
Avg: 83.1
61.8029
Quality
65.2131
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where SHILPA AKULA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ARNOT OGDEN MEDICAL CENTER
★★☆☆☆ 2/5
ELMIRA, NY
Acute Care Hospitals
CMS CCN: 330090

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SHILPA AKULA, MD. Source: openpaymentsdata.cms.gov.

Total received

$214

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to SHILPA AKULA, MD. To verify SHILPA AKULA, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

SHILPA AKULA, MD — brand share 11.0%
Specialty average (est.)

11% brand-name claims vs 89% generic, on 2,337 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,337
Total Claims
$171K
Total Drug Cost
194
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,205
Total Day Supply
122,516
Brand vs Generic
11% brand / 89% generic
Brand Drug Cost
$124K
Generic Drug Cost
$46K
Opioid Claims
82 (3.5% rate)
Antibiotic Claims
35

Patient Demographics

Average Patient Age
69.0 years
Avg HCC Risk Score
1.33
Gender Split
66% female / 34% male
Age Distribution
<65: 51, 65-74: 84, 75-84: 34, 85+: 25

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SHILPA AKULA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
89
Lisinopril
82
Gabapentin
78
Pantoprazole Sodium
77
Levothyroxine Sodium
68
Metoprolol Succinate
68
Potassium Chloride
62
Omeprazole
60
Furosemide
59
Sertraline Hcl
51

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How SHILPA AKULA, MD fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

SHILPA AKULA, MD's 2,337 claims are below the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as AKULA.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SHILPA AKULA, MD's specialty?
SHILPA AKULA, MD specializes in Internal Medicine Physician and practices in ELMIRA, New York. Credentials: MD.
How much does SHILPA AKULA, MD prescribe under Medicare Part D?
In 2023, SHILPA AKULA, MD wrote 2,337 Medicare Part D claims totaling $171K in drug costs for 194 beneficiaries.
What is SHILPA AKULA, MD's Medicare quality score?
SHILPA AKULA, MD has a CMS MIPS Final Score of 81.3099/100 (Quality: 61.8029, Cost: 65.2131). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SHILPA AKULA, MD located?
SHILPA AKULA, MD is located at 200 MADISON AVE FL 3, ELMIRA, NY, 14901. Phone: (607) 734-1581.
What is SHILPA AKULA, MD's NPI number?
SHILPA AKULA, MD's National Provider Identifier (NPI) is 1578003430, issued on 02/26/2017.
Does SHILPA AKULA, MD prescribe more brand-name or generic drugs?
SHILPA AKULA, MD's prescribing is 11% brand-name and 89% generic drugs by claim count, with $124K in brand drug costs.
Does SHILPA AKULA, MD prescribe opioids?
Yes, SHILPA AKULA, MD had 82 opioid claims in 2023 with an opioid prescribing rate of 3.5%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does SHILPA AKULA, MD prescribe most often?
Based on 2023 Medicare Part D data, SHILPA AKULA, MD's most frequently prescribed drugs include Atorvastatin Calcium, Lisinopril, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SHILPA AKULA, MD accept Medicare?
SHILPA AKULA, MD appears in CMS Medicare data with 2,337 Part D claims and 194 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SHILPA AKULA, MD's credentials?
SHILPA AKULA, MD's NPI is 1578003430 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology